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Toscana virus (TOSV) is an arthropodborne virus first
identified in 1971 from the sandfly Phlebotomus pernicio-
sus in central Italy. Many case reports in travelers and clin-
ical research and epidemiologic studies conducted around
the Mediterranean region have shown that TOSV has a tro-
pism for the central nervous system (CNS) and is a major
cause of meningitis and encephalitis in countries in which it
circulates. In central Italy, TOSV is the most frequent cause
of meningitis from May to October, far exceeding
enteroviruses. In other northern Mediterranean countries,
TOSV is among the 3 most prevalent viruses associated
with meningitis during the warm seasons. Therefore, TOSV
must be considered an emerging pathogen. Here, we
review the epidemiology of TOSV in Europe and determine
questions that should be addressed in future studies.
Despite increasing evidence of its major role in medicine as
an emerging cause of CNS infections, TOSV remains an
unstudied pathogen, and few physicians are aware of its
potential to cause CNS infections. 
T
oscana virus (TOSV) was originally isolated in 1971
from the sandfly Phlebotomus perniciosus collected in
Monte Argentario (Grosseto province, central Italy) (1,2).
Thus far, most clinical and epidemiologic studies have
been conducted in Italy, although studies from other
Mediterranean countries have been published recently.
From these, TOSV appears to be 1 of the 3 major viral
pathogens involved in aseptic meningitis acquired during
the summer in these countries. A bibliographic search
using “Toscana virus” as keyword in the PubMed database
retrieved 54 research and review articles. Less than 50% of
them report imported or autochthonous human cases
acquired in Italy, Spain, Portugal, France, and Cyprus.
Even though evidence that TOSV plays a major role in
human disease is increasing, it remains poorly studied, and
physicians have little awareness of its potential to cause
CNS infections. 
Virus Properties and Classification
According the 8th report of the International
Committee on Taxonomy of Viruses, TOSV is a serotype
of Sandfly fever Naples virus within the genus
Phlebovirus in the family Bunyaviridae. TOSV is an
arthropodborne virus. The lack of biochemical and genet-
ic data for most phleboviruses dictates that the species are
defined by serologic relationships and are distinguishable
by 4-fold differences in 2-way neutralization tests.
Phleboviruses contain a negative-sense, single-stranded
RNA genome that consists of 3 segments, designated
large, medium, and small, which encode the RNA-
dependent RNA polymerase, the envelope glycoproteins,
and the nucleoprotein, respectively.
Epidemiology of Phleboviruses 
and Toscana Virus
Phlebotomus (sandfly) fever viruses have been isolated
from sandflies in southern Europe, Africa, central Asia,
and the Americas, and evidence exists for the presence of
different viruses in the same sandfly population. Sandfly
fever Naples (but not the TOSV serotype) and Sicilian
viruses have the widest geographic distribution, in parallel
to their vector’s (Phlebotomus papatasi) distribution. Until
recent years, the known distribution of TOSV was limited
to Italy and Portugal (3,4). In Italy, the virus was isolated
from the vectors P. perniciosus and Phlebotomus perfiliewi
and from humans, whereas the presence of the virus in
Portugal was suspected on the basis of a strain isolated
from the cerebrospinal fluid (CSF) of a Swedish patient
who was returning to his home country from Portugal.
More recently, the geographic distribution of the virus has
been extended to France, Spain, Slovenia, Greece, Cyprus,
and Turkey, according to results from viral isolation and
serologic surveys (5–9).
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Italy
Preliminary clues pointing to the role of TOSV in CNS
infections in Italy were provided by reports of imported
cases diagnosed in the United States (10) and Germany
(11). A large study carried out from 1977 to 1988 showed
that the virus was the cause of meningitis in 2 regions of
Italy, Tuscany and Marche, with a seasonal peak in August,
which corresponded to the peak of sandfly activity (3).
Since then, the virus has been isolated in other regions of
central and southern Italy. More recently, research into
TOSV as an etiologic agent of neurologic diseases has
been carried out in Emilia-Romagna and Piedmont (12).
Striking evidence that TOSV was the most prominent viral
etiologic agent in summertime meningitis was reported in
the late 1990s (13); in one of the most comprehensive stud-
ies, TOSV represented 81% of the viruses detected in CSF
from patients who sought treatment for meningitis and
other CNS infections (14). TOSV sequences were detected
in 85 of 104 CSF specimens that provided positive results
for viral sequence; However, 173 CSF specimens were
negative by polymerase chain reaction (PCR); therefore,
TOSV sequences were detected in 30% of the patients
admitted for meningitis and in 40% of the patients admit-
ted from June to November. A study of children living in
rural or suburban areas of Siena (central Italy) showed that
40% of meningitis or encephalitis cases could be linked to
TOSV infection (15). A 7-year study performed in Siena
showed that 52% of aseptic meningitis cases in adults were
associated with TOSV (seroconversion, presence of
immunoglobulin M [IgM], PCR detection) (16). All stud-
ies agree regarding the monthly distribution of human
cases of TOSV infections: the highest risk of acquiring
TOSV is in August, then July and September, and finally
June and October. Populations living in rural areas and
with high levels of outdoor activity are at the greatest risk
of TOSV infection. An occupational risk study conducted
on forestry workers in Siena, Florence, and Arezzo showed
that 77.2% of them had positive IgG for TOSV, compared
with an urban population who exhibited a 22% prevalence
for IgG. In contrast, 6% of forestry workers of the
Piedmont area showed TOSV IgG (17). The first report of
TOSV infection in Umbria was published in 2003 in the
form of a retrospective study of 93 aseptic meningitis and
meningoencephalitis cases. Of interest is the observed
16% of the healthy control population who were IgG pos-
itive (12). TOSV infections in Emilia-Romagna were doc-
umented for the first time in 2002 (18).
France
The first case of TOSV infection acquired in France
was reported in a German traveler who was returning from
southern France (19). During surveillance for West Nile
virus in southern France, serum specimens from patients
with suspected cases (meningitis) were tested for TOSV,
and several contained specific IgM. Two cases of meningi-
tis caused by TOSVwere diagnosed by seroconversion and
by viral isolation (6). Two cases (1 meningitis and 1 febrile
illness) were recently reported (5). Together, data confirm
that TOSV circulates in southeastern France and causes
disease in humans. 
Spain
The first case of TOSV infection reported from Spain
occurred in a Swedish tourist after a visit to Catalonia and
was documented by plaque reduction neutralization test
(PRNT) (20). In the last 3 years, Spanish researchers and
physicians have reported many cases and conducted large
epidemiologic studies that established TOSV as 1 of the 3
leading causes of meningitis in Spain (Figure 1)
(8,21,22,23). A large study conducted in different regions
of Spain showed the presence of IgG antibodies to TOSV
(26.2%), sandfly fever Naples virus (2,2%), and sandfly
fever Sicilian virus (11.9%) in 1,181 adults and 87 children
(21). In 2003, the EVITAR (Enfermedades Viricas
Transmitidas por Artropodos y Roederes) network for the
study of arthropod- and rodentborne viral diseases was cre-
ated and sponsored by the Spanish Ministry of Health.
Within this context, a study on seroprevalence in Granada
showed a 24.9% seroprevalence rate. A significant
increase was observed with age (9.4% in persons <15
years vs. 60.4% in persons >65 years). In addition, several
cases of TOSV have been documented in the south, cen-
tral, and Mediterranean areas. These data suggest that the
situation in Spain is similar to that observed in France,
with lower prevalence of CNS infections than that
observed in central Italy.
Cyprus
Several studies were conducted in Swedish United
Nations soldiers based in Cyprus in 1985. Blood samples
were obtained from a 362-soldier battalion just before and
immediately after their 6-month tour of duty. Of 298 serum
pairs available, seroconversion to TOSV was observed in
1 patient who did not show any clinical manifestations (9).
Seroprevalence studies showed that 20% of the healthy
population had TOSV IgG (23). 
Greece
Phleboviruses are found in Greece (24). Recent studies
of populations living on the Ionian Islands and western
mainland of Greece showed a seroprevalence of 60% and
35% respectively, by enzyme-linked immunosorbent assay
(ELISA). However, so far, no studies have reported menin-
gitis or encephalitis cases caused by TOSV in Greece. 
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To date, Sweden has had 1 imported case in a man who
had a severe headache and fever without neck stiffness after
returning from Portugal. Viral isolation was successful and
identification was performed by plaque neutralization (4).
In addition, 1 German patient returning from vacation in
Portugal had meningitis; diagnosis was established by
ELISA and confirmed by immunoblot assay (25).
Germany
In a seroepidemiologic survey of 859 healthcare work-
ers and medical students, anti-TOSV IgG was detected in
1.0% of samples by immunofluorescent assay (IFA), and
in 0.7% by enzyme immunoassay (EIA). In 2,034 German
patients, who were hospitalized for various diseases, 1.6%
were positive for anti-TOSV IgG by IFA, and 0.8% by
EIA. Anti-TOSV IgG was detected in 43 samples of com-
mercial immunoglobulins at titers of 10–1,000 by EIA.
Although the seroprevalence of antibodies to TOSV is low
in Germany, TOSV infection should be considered in
patients returning from virus-endemic areas who have
fever and headaches or symptoms of meningitis (26).
Cycle in Nature
Vectors
TOSV was isolated from P. perniciosus and P. perfil-
iewi but never from P. papatasi. TOSV has also been iso-
lated from the brains of the bat Pipistrellus kuhli, which
was trapped in areas where P. perniciosus and P. perfiliewi
are found (1,2). Transovarial transmission has been
demonstrated in the laboratory and by viral isolation from
male Phlebotomus spp. Venereal transmission from infect-
ed males to uninfected females has also been demonstrat-
ed.  P.  perniciosus is distributed throughout the
Mediterranean region as 2 races. The typical P. pernicio-
sus race occurs in Italy as well as in Malta, Tunisia, and
Morocco. The Iberian race replaces it in southern Spain
(with the pni mtDNA sublineage) (27). 
Reservoir
The reservoir of TOSV is most likely the vector.
Neither mammals nor birds have been recognized as a
potential reservoir, although few studies have been carried
out on mammals and almost none on birds. Whether
humans can play a role in the virus cycle by infecting naïve
sandflies is not known. 
Although a number of phleboviruses have been isolat-
ed from the blood of sick persons and from wild animals,
the role of vertebrates in the maintenance of the transmis-
sion cycle of these viruses remains unclear. Transient and
low-level viremia is present after phlebovirus infection in
humans and in susceptible laboratory animals (28–30).
Moreover, sandflies must ingest a large quantity of virus to
become infected (31). Verani et al. (1) examined different
species of wild vertebrates (wild mouse, bank vole, stone
marten, coypus, porcupine, bat, fox, and hedgehog)
through serologic testing and viral isolation.
Disease in Humans 
Clinical Forms 
Seroprevalence studies suggest that a proportion of
infections by TOSV are asymptomatic or paucisympto-
matic. Additional studies will be necessary to evaluate the
ratio of symptomatic versus asymptomatic or paucisymp-
tomatic infections.
In some cases, TOSV infection causes a self-limiting
febrile illness without CNS manifestations; these patients
are not usually hospitalized, and their cases are not usual-
ly investigated further. This fact may account for the
probable underestimation of TOSV infection rates.
After an incubation period ranging from a few days to
2 weeks, disease onset is intense (70%) with headache
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Figure 1. Provinces of Italy and
Spain in which clinical cases of
Toscana virus (TOSV) infection have
been documented, and seropreva-
lence studies were conducted. PCR,
polymerase chain reaction; IgM,
immunoglobulin M.(100%, 18 h–5 days), fever (76%–97%), nausea and vom-
iting (67%–88%), and myalgias (18%). Physical examina-
tion may show neck rigidity (53%–95%), Kernig signs
(87%), poor levels of consciousness (12%), tremors
(2.6%), paresis (1.7%), and nystagmus (5.2%) (L.
Nicoletti, pers. comm.). In most cases reported so far, CSF
contained >5–10 cells with normoglycorachia and normo-
proteinorachia. Blood samples may show leukocytosis
(29%) or leukopenia (6%). The mean duration of the dis-
ease is 7 days, and the outcome is usually favorable.
Although TOSV infection in most cases consists of a
mild disease with a favorable outcome, a small number of
severe cases have been reported in the literature. Two
young brothers and a sister living in Umbria experienced
TOSV infection in the form of severe meningoencephalitis
with stiff neck, deep coma, maculopapular rash, diffuse
lymphadenopathy, hepatosplenomegaly, renal involve-
ment, skin rash with lamellar desquamation, a tendency to
bleed, and diffuse intravascular coagulopathy. CNS mani-
festations occurred after 3 weeks of fever. Convalescence
was marked by hydrocephalus that required a ventriculoa-
trial shunt. Diagnosis was established by serologic means
and by PCR sequencing (32). Two cases of encephalitis
without meningitis were recently diagnosed by serologic
testing and by detecting TOSV sequences in CSF (33).
One case of meningitis, complicated by abducens nerve
palsy, was reported (34). To date, no published data exist
that suggest that TOSV causes any other manifestations.
However, a substantial proportion of infection likely
results in asymptomatic or paucisymptomatic cases (5,35).
Laboratory Diagnosis
Serologic Testing
Seroconversion and the detection of IgG, IgM, or both,
can be achieved in cells infected with TOSV. However,
cross-reactivity exists between members of the genus
Phlebovirus and specifically between TOSV and other
serotypes of sandfly fever Naples virus.
ELISAs have been developed with either crude antigens
or purified virus obtained from infected cells. The advan-
tage of ELISA resides in its capacity to rapidly test a large
number of specimens; however, cross-reactions most likely
will be observed. Recently, an ELISA test based on a
recombinant nucleoprotein gene was developed and is now
available commercially from an Italian company. Recent
seroprevalence studies were based on this test (8,21).
PRNT is the test of choice when the virus species must
be confirmed. Therefore, seroprevalence data must be
carefully interpreted since in most cases, analyses were
performed with ELISA or IFA that cannot discriminate
between sandfly fever Naples virus, sandfly fever Sicilian
virus, and TOSV.
Virus Isolation
Viruses can be isolated from clinical samples by using
CSF but not serum. CSF specimens that yield virus
through cell culture are collected in the first 2–4 days of
the disease. 
TOSV replicates in a variety of animals. Intracranial,
intraperitoneal, and subcutaneous routes lead to death in
newborn mice, and intracranial and intraperitoneal routes
lead to death in weanling mice. This effect is seen with
viruses from only a few families, including flaviviruses,
which are also implicated in viral encephalitis. In guinea
pigs and rabbits, intracranial injection results in paralysis
and death, whereas intraperitoneal injection is not fatal and
results in antibody synthesis. 
TOSV replicates in Vero, BHK-21, CV-1, and SW13
cells with cytopathic effect and not in C6/36 cells.
However, cell culture appears to have a low sensitivity for
detecting TOSV since only 14% of the PCR-positive CSF
specimens added to Vero cells led to viral isolation.
Molecular Techniques
In some cases, the relatively low level of virus in blood
and CSF samples hampers attempts to isolate the virus. In
such cases, molecular techniques based on PCR are more
sensitive than IgM detection or viral isolation. Three dif-
ferent methods for molecular diagnosis of TOSV have
been developed (Table). To date, all studies aimed at the
molecular detection of TOSV sequences in the CSF of
patients with meningitis or other CNS manifestations have
used classic PCR detection through single-round or nested
protocols. Tests of an RT-PCR assay alone, without a fur-
ther nested PCR step, showed that this method did not
appear to be valid for detecting TOSV, since no sample
was positive after the first reaction. Two systems (14,36)
use specific primers in the S segment, and the other is
based on degenerate oligonucleotides targeting of the L
segment (37). The most widely used has been successful
for TOSV diagnosis in Italy (13) and France (R. Charrel et
al. unpub. data). In 2003, a new method for detecting
TOSV of Italian or Spanish origin was produced by using
degenerate primers. The description of 2 genotypes of
TOSV demonstrates a need for caution when designing
molecular methods for diagnosis to avoid false-negative
results. Recently, real-time PCR systems, including a fluo-
rescent dye–labeled probe, have dramatically reduced the
risk of contamination. The sensitivity of real time RT-PCR
is close to that obtained by nested PCR protocols, and the
results are obtained within 3 hours. However, to develop
real-time PCR assays that detect all variants of TOSV cir-
culating in Mediterranean countries and causing diseases
in humans, a considerable amount of work must be done to
determine the sequences of strains reflecting viral hetero-
geneity observed in different countries. The recent report
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strains circulating in Italy, which is not detected by PCR
systems previously reported in Italy, underlines the
requirement for a large program of strain isolation and full-
length genome sequencing to achieve this goal.
Genetic Diversity of TOSV Strains
Strains Isolated
The prototype TOSV strain, ISS Phl.3, isolated from P.
perniciosus in 1971 has been completely sequenced. A
total of 84 virus strains were obtained from 16,374 male
and female sandflies (P. perniciosus and P. perfiliewi) col-
lected in 2 localities of the Tuscany region of Italy between
1980 and 1985. Thirty-seven (44%) were identified as
TOSV and 47 (56%) as a new member of the phlebotomus
fever serogroup, Arbia virus. The overall virus isolation
rate from sandflies was 0.5%. Viral isolation rates for both
viruses were similar in different years and in the 2 locali-
ties, suggesting that the 2 virus types were active in the
sandfly population simultaneously (maximum activity in
July) (3). Seventeen strains of TOSV have been isolated in
Spain from patient specimens (22). Several strains have
been isolated in southeastern France from patients with
clinical cases and remain to be characterized. 
Genetic Diversity
A number of strains from Italy have been partially
sequenced, and only minor differences in the nucleopro-
tein were found among strains isolated in the early 1980s
from both species of sandflies, from the bat, and from
humans, with <1 amino acid substitution (L. Nicoletti,
pers. comm.). Similar results were described in a study on
some variants in the N gene of strains isolated from
humans from 1995 to 1998; only 1 variant showed a single
amino acid substitution of an 80-amino-acid region (38).
Changes in the amino acid sequence that make this protein
less efficient in its interaction with the viral nucleic acid
may kill the virus.
A different situation has been described in Spain for
partial sequences in the large segment encoding the poly-
merase activity. Aphylogenetic analysis performed from L
segment sequences obtained from 11 clinical isolates from
Granada and compared with the homologous sequence of
an Italian reference strain showed that Spanish sequences
were closely related to one another and distantly related to
the Italian strain (37). This finding suggests the presence of
at least 2 geographically distinct populations of TOSV.
Phylogeny and Evolution 
To date, sequence data are too scarce to perform signif-
icant phylogenetic analyses. We must therefore set up a
large program of complete genome sequencing of the
strains collected in different regions and simultaneously to
encourage the development of viral isolation programs in
all countries surrounding the Mediterranean where vectors
are circulating to better understand the genetic diversity,
phylogenetic relationships, and mechanisms driving the
evolution of TOSV (Figure 2). 
Future Concerns
Nature of the Vector in Different Regions
The virus has been isolated from P. perfiliewi and P.
perniciosus, the most abundant sandfly species present in
Italy. However, other vector species, found in different
Toscana Virus in Europe
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results indicate that the virus is present in many areas of
the Mediterranean basin. Entomologic studies must be
conducted to better understand the distribution and identi-
fication of potential vectors of TOSV.
TOSV and Blood Donation
The recent introduction of West Nile virus into North
America has stimulated a renewed interest among health
authorities regarding arthropodborne viruses, specifically
concerning human blood products. Until 2002, the risk of
transmitting West Nile virus to a naïve patient from a blood
donation was considered negligible, given the supposed
short time (≈6 days) and low viremia titers. However, ≈30
cases of viral transmission were documented in 2002 and
2003 in the United States and Canada, as well as cases of
West Nile virus infections after organ transplantation from
a viremic donor. Moreover, 540 positive blood donation
samples were detected by using PCR, which underlines the
necessity of this kind of test in an epidemiologic situation
similar to that seen in the United States. Recent data on
TOSV circulation in Mediterranean countries during the
summer raise concerns about potential implications for
blood donations. 
Genotypes and Their Distribution
Limited studies have been conducted on the genetic
variability of TOSV. The work of Sanchez-Seco on the L
segment demonstrated the presence of 2 geographically
distinct populations of the virus (37). However, the study
was performed on strains isolated from patients with acute
neurologic disease. On the basis of seroprevalence in a
healthy population, Magurano and Nicoletti hypothesized
that among the different strains of TOSV that may circu-
late in the same area and infect humans, only a few cause
severe disease, whereas most strains induce antibody
response with minor or no symptoms of illness (39). The
role of different strains in the symptoms and influence on
the severity of TOSV infection requires clarification.
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